Enteroviruses and type 1 diabetes

Diabetes/Metabolism Research and Reviews

Volumn 19, Issue 6, 2003, Pages 431-441

  Varela Calvino, Ruben ^a   Peakman, Mark ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Autoimmunity; Coxsackievirus B; Diabetes; Enteroviruses

Indexed keywords

SUPERANTIGEN; VIRUS ANTIBODY; VIRUS RNA;

AUTOIMMUNITY; DISEASE ASSOCIATION; ENTEROVIRUS INFECTION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MOLECULAR MIMICRY; NONHUMAN; PATHOGENESIS; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SEROLOGY; T LYMPHOCYTE ACTIVATION; VIRUS DETECTION; VIRUS GENOME; VIRUS ISOLATION;

AUTOIMMUNE DISEASES; DIABETES MELLITUS, TYPE 1; ENTEROVIRUS INFECTIONS; HUMANS; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

EID: 0348038691     PISSN: 15207552     EISSN: None     Source Type: Journal    
DOI: 10.1002/dmrr.407     Document Type: Review

References (99)

1. Kimpimaki T, Kupila A, Hamalainen AM, et al. The first signs of beta-cell autoimmunity appear in infancy in genetically susceptible children from the general population: the Finnish type 1 diabetes prediction and prevention study. J Clin Endocrinol Metab 2001; 86: 4782-4788.
2. Kaprio J, Tuomilehto J, Koskenvuo M, et al. Concordance for type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus in a population-based cohort of twins in Finland. Diabetologia 1992; 35: 1060-1067.
3. Kumar D, Gemayel NS, Deapen D, et al. North-American twins with IDDM. Genetic, etiological, and clinical significance of disease concordance according to age, zygosity, and the interval after diagnosis in first twin. Diabetes 1993; 42: 1351-1363.
4. Salvetti M, Ristori G, Bomprezzi R, Pozzilli P, Leslie RD. Twins: mirrors of the immune system. Immunol Today 2000; 21: 342-347.
5. Redondo MJ, Yu L, Hawa M, et al. Heterogeneity of type I diabetes: analysis of monozygotic twins in Great Britain and the United States. Diabetologia 2001; 44: 354-362.
6. Petersen JS, Kyvik KO, Bingley PJ, et al. Population based study of prevalence of islet cell autoantibodies in monozygotic and dizygotic Danish twin pairs with insulin dependent diabetes mellitus. BMJ 1997; 314: 1575-1579.
7. Feltbower RG, Bodansky HJ, McKinney PA, Houghton J, Stephenson CR, Haigh D. Trends in the incidence of childhood diabetes in south Asians and other children in Bradford, UK. Diabet Med 2002; 19: 162-166.
8. Karvonen M, Tuomilehto J, Libman I, LaPorte R. World Health Organization DIAMOND Project Group. A review of the recent epidemiological data on the worldwide incidence of type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1993; 36: 883-892.
9. Forrest JM, Menser MA, Burgess JA. High frequency of diabetes mellitus in young adults with congenital rubella. Lancet 1971; 2: 332-334.
10. Hyoty H, Leinikki P, Reunanen A, et al. Mumps infections in the etiology of type 1 (insulin-dependent) diabetes. Diabetes Res 1988; 9: 111-116.
11. Ward KP, Galloway WH, Auchterlorrie IA. Congenital cytomegalovirus infection and diabetes. Lancet 1979; 1: 497.
12. Honeyman MC, Coulson BS, Stone NL, et al. Association between rotavirus infection and pancreatic islet autoimmunity in children at risk of developing type 1 diabetes. Diabetes 2000; 49: 1319-1324.
13. Lonnrot M, Korpela K, Knip M, et al. Enterovirus infection as a risk factor for beta-cell autoimmunity in a prospectively observed birth cohort: the Finnish diabetes prediction and prevention study. Diabetes 2000; 49: 1314-1318.
14. Akerblom HK, Knip M. Putative environmental factors in type 1 diabetes. Diabetes Metab Rev 1998; 14: 31-67.
15. Hyoty H, Taylor KW. The role of viruses in human diabetes. Diabetologia 2002; 45: 1353-1361.
16. Yoon JW, Austin M, Onodera T, Notkins AL. Isolation of a virus from the pancreas of a child with diabetic ketoacidosis. N Engl J Med 1979; 300: 1173-1179.
17. Tracy S, Drescher KM, Chapman NM, et al. Toward testing the hypothesis that group B coxsackieviruses (CVB) trigger insulin-dependent diabetes: inoculating nonobese diabetic mice with CVB markedly lowers diabetes incidence. J Virol 2002; 76: 12 097-12 111.
18. Hartig PC, Madge GE, Webb SR. Diversity within a human isolate of coxsackie B4: relationship to viral-induced diabetes. J Med Virol 1983; 11: 23-30.
19. Chatterjee NK, Nejman C, Gerling I. Purification and characterization of a strain of coxsackievirus B4 of human origin that induces diabetes in mice. J Med Virol 1988; 26: 57-69.
20. Banatvala JE, Bryant J, Schernthaner G, et al. Coxsackie B, mumps, rubella, and cytomegalovirus specific IgM responses in patients with juvenile-onset insulin-dependent diabetes mellitus in Britain, Austria, and Australia. Lancet 1985; 1: 1409-1412.
21. Helfand RF, Gary Jr HE, Freeman CY, Anderson LJ, Pallansch MA. Pittsburgh Diabetes Research Group. Serologic evidence of an association between enteroviruses and the onset of type 1 diabetes mellitus. J Infect Dis 1995; 172: 1206-1211.
22. Hyoty H, Hiltunen M, Knip M, et al. Childhood Diabetes in Finland (DiMe) Study Group. A prospective study of the role of coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Diabetes 1995; 44: 652-657.
23. Roivainen M, Knip M, Hyoty H, et al., Childhood Diabetes in Finland (DiMe) Study Group. Several different enterovirus serotypes can be associated with prediabetic autoimmune episodes and onset of overt IDDM. J Med Virol 1998; 56: 74-78.
24. Lonnrot M, Knip M, Roivainen M, Koskela P, Akerblom HK, Hyoty H. Onset of type 1 diabetes mellitus in infancy after enterovirus infections. Diabet Med 1998; 15: 431-434.
25. Otonkoski T, Roivainen M, Vaarala O, et al. Neonatal type I diabetes associated with maternal echovirus 6 infection: a case report. Diabetologia 2000; 43: 1235-1238.
26. Tuvemo T, Dahlquist G, Frisk G, et al. The Swedish childhood diabetes study III: IgM against coxsackie B viruses in newly diagnosed type 1 (insulin-dependent) diabetic children-no evidence of increased antibody frequency. Diabetologia 1989; 32: 745-747.
27. Fuchtenbusch M, Irnstetter A, Jager G, Ziegler AG. No evidence for an association of coxsackie virus infections during pregnancy and early childhood with development of islet autoantibodies in offspringof mothers or fathers with type 1 diabetes. J Autoimmun 2001; 17: 333-340.
28. Salminen K, Sadeharju K, Lonnrot M, et al. Enterovirus infections are associated with the induction of beta-cell autoimmunity in a prospective birth cohort study. J Med Virol 2003; 69: 91-98.
29. Clements GB, Galbraith DN, Taylor KW. Coxsackie B virus infection and onset of childhood diabetes. Lancet 1995; 346: 221-223.
30. Lonnrot M, Salminen K, Knip M, et al. Childhood Diabetes in Finland (DiMe) Study Group. Enterovirus RNA in serum is a risk factor for beta-cell autoimmunity and clinical type 1 diabetes: a prospective study. J Med Virol 2000; 61: 214-220.
31. Andreoletti L, Heber D, Hober-Vandenberghe C, et al. Detection of coxsackie B virus RNA sequences in whole blood samples from adult patients at the onset of type I diabetes mellitus. J Med Virol 1997; 52: 121-127.
32. Nairn C, Galbraith DN, Taylor KW, Clements GB. Enterovirus variants in the serum of children at the onset of type 1 diabetes mellitus. Diabet Med 1999; 16: 509-513.
33. Chehadeh W, Weill J, Vantyghem MC, et al. Increased level of interferon-alpha in blood of patients with insulin-dependent diabetes mellitus: relationship with coxsackievirus B infection. J Infect Dis 2000; 181: 1929-1939.
34. Foulis AK, McGill M, Farquharson MA, Hilton DA. A search for evidence of viral infection in pancreases of newly diagnosed patients with IDDM. Diabetologia 1997; 40: 53-61.
35. Jones DB, Crosby I. Proliferative lymphocyte responses to virus antigens homologous to GAD65 in IDDM. Diabetologia 1996; 39: 1318-1324.
36. Juhela S, Hyoty H, Hinkkanen A, et al. T cell responses to enterovirus antigens and to beta-cell autoantigens in unaffected children positive for IDDM-associated autoantibodies. J Autoimmun 1999; 12: 269-278.
37. Juhela S, Hyoty H, Roivainen M, et al. T-cell responses to enterovirus antigens in children with type 1 diabetes. Diabetes 2000; 49: 1308-1313.
38. Varela-Calvino R, Sgarbi G, Arif S, Peakman M. T-Cell reactivity to the P2C nonstructural protein of a diabetogenic strain of coxsackievirus B4. Virology 2000; 274: 56-64.
39. Marttila J, Juhela S, Vaarala O, et al. Responses of coxsackievirus B4-specific T-cell lines to 2C protein-characterization of epitopes with special reference to the GAD65 homology region. Virology 2001; 284: 131-141.
40. Varela-Calvino R, Ellis R, Sgarbi G, Dayan CM, Peakman M. Characterization of the T-cell response to coxsackievirus B4: evidence that effector memory cells predominate in patients with type 1 diabetes. Diabetes 2002; 51: 1745-1753.
41. Martrila J, Hyoty H, Vilja P, et al. T cell epitopes in coxsackievirus B4 structural proteins concentrate in regions conserved between enteroviruses. Virology 2002; 293: 217-224.
42. Klemetti P, Hyoty H, Roivainen M, et al. Relation between T-cell responses to glutamate decarboxylase and coxsackievirus B4 in patients with insulin-dependent diabetes mellitus. J Clin Virol 1999; 14: 95-105.
43. Roep BO. Immunology of Diabetes Society T-cell Committee. Standardization of T-cell assays in Type I diabetes. Diabetologia 1999; 42: 636-637.
44. Varela-Calvino R, Sgarbi G, Wedderburn LR, Dayan CM, Tremble J, Peakman M. T cell activation by coxsackievirus b4 antigens in type 1 diabetes mellitus: evidence for selective tcr vbeta usage without superantigenic activity. J Immunol 2001; 167: 3513-3520.
45. Berlin LE, Rorabaugh ML, Heldrich F, Roberts K, Doran T, Modlin JF. Aseptic meningitis in infants <2 years of age: diagnosis and etiology. J Infect Dis 1993; 168: 888-892.
46. Hiltunen M, Hyoty H, Knip M, et al. Childhood Diabetes in Finland (DiMe) Study Group. Islet cell antibody seroconversion in children is temporally associated with enterovirus infections. J Infect Dis 1997; 175: 554-560.
47. Cainelli F, Manzaroli D, Renzini C, Casali F, Concia E, Vento S. Coxsackie B virus-induced autoimmunity to GAD does not lead to type 1 diabetes. Diabetes Care 2000; 23: 1021-1022.
48. Vreugdenhil GR, Schloot NC, Hoorens A, et al. Acute onset of type I diabetes mellitus after severe echovirus 9 infection: putative pathogenic pathways. Clin Infect Dis 2000; 31: 1025-1031.
49. Smith CP, Clements GB, Riding MH, Collins P, Botrazzo GF, Taylor KW. Simultaneous onset of type 1 diabetes mellitus in identical infant twins with enterovirus infection. Diabet Med 1998; 15: 515-517.
50. Oldstone MB. Molecular mimicry and autoimmune disease. Cell 1987; 50: 819-820.
51. Vreugdenhil GR, Batstra MR, Aanstoot HJ, Melchers WJ, Galama JM. Analysis of antibody responses against coxsackie virus B4 protein 2C and the diabetes autoantigen GAD(65). J Med Virol 1999; 59: 256-261.
52. Harkonen T, Lankinen H, Davydova B, Hovi T, Roivainen M. Enterovirus infection can induce immune responses that crossreact with beta-cell autoantigen tyrosine phosphatase IA-2/IAR. J Med Virol 2002; 66: 340-350.
53. Wucherpfennig KW, Strominger JL. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 1995; 80: 695-705.
54. Mason D. A very high level of crossreactivity is an essential feature of the T-cell receptor. Immunol Today 1998; 19: 395-404.
55. Davis MM, Bjorkman PJ. T-cell antigen receptor genes and T-cell recognition. Nature 1988; 334: 395-402.
56. Hiemstra HS, Schloot NC, van Veelen PA, et al. Cytomegalovirus in autoimmunity: T cell crossreactivity to viral antigen and autoantigen glutamic acid decarboxylase. Proc Natl Acad Sci USA 2001; 98: 3988-3991.
57. Hou J, Said C, Franchi D, Dockstader P, Chatterjee NK. Antibodies to glutamic acid decarboxylase and P2-C peptides in sera from coxsackie virus 134-infected mice and IDDM patients. Diabetes 1994; 43: 1260-1266.
58. Lonnrot M, Hyoty H, Knip M, et al. Childhood Diabetes in Finland Study Group. Antibody cross-reactivity induced by the homologous regions in glutamic acid decarboxylase (GAD65) and 2C protein of coxsackievirus B4. Clin Exp Immunol 1996; 104: 398-405.
59. Tian J, Lehmann PV, Kaufman DL. T cell cross-reactivity between coxsackievirus and glutamate decarboxylase is associated with a murine diabetes susceptibility allele. J Exp Med 1994; 180: 1979-1984.
60. Atkinson MA, Bowman MA, Campbell L, Darrow BL, Kaufman DL, MaClaren NK. Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin-dependent diabetes. J Clin Invest 1994; 94: 2125-2129.
61. Schloot NC, Willemen SJ, Duinkerken G, Drijfhout JW, de Vries RR, Roep BO. Molecular mimicry in type 1 diabetes mellitus revisited: T-cell clones to GAD65 peptides with sequence homology to Coxsackie or proinsulin peptides do not crossreact with homologous counterpart. Hum Immunol 2001; 62: 299-309.
62. Olson JK, Croxford JL, Calenoff MA, Dal Canto MC, Miller SD. A virus-induced molecular mimicry model of multiple sclerosis. J Clin Invest 2001; 108: 311-318.
63. Harkonen T, Puolakkainen M, Sarvas M, Airaksinen U, Hovi T, Roivainen M. Picornavirus proteins share antigenic determinants with heat shock proteins 60/65. J Med Virol 2000; 62: 383-391.
64. Horwitz MS, Bradley LM, Harbertson J, Krahl T, Lee J, Sarvetnick N. Diabetes induced by coxsackie virus: initiation by bystander damage and not molecular mimicry. Nat Med 1998; 4: 781-785.
65. Serreze DV, Ottendorfer EW, Ellis TM, Gauntt CJ, Atkinson MA. Acceleration of type 1 diabetes by a coxsackievirus infection requires a preexisting critical mass of autoreactive T-cells in pancreatic islets. Diabetes 2000; 49: 708-711.
66. Vreugdenhil GR, Wijnands PG, Netea MG, van der Meer JW, Melchers WJ, Galama JM. Enterovirus-induced production of pro-inflammatory and T-helper cytokines by human leukocytes. Cytokine 2000; 12: 1793-1796.
67. Cunningham JM, Green IC. Cytokines, nitric oxide and insulin secreting cells. Growth Regul 1994; 4: 173-180.
68. Zanone MM, Favaro E, Conaldi PG, et al. Persistent infection of human microvascular endothelial cells by coxsackie B viruses induces increased expression of adhesion molecules. J Immunol 2003; 171: 438-446.
69. Foulis AK, Farquharson MA, Meager A. Immunoreactive alpha-interferon in insulin-secreting beta cells in type 1 diabetes mellitus. Lancet 1987; 2: 1423-1427.
70. Huang X, Yuang J, Goddard A, et al. Interferon expression in the pancreases of patients with type I diabetes. Diabetes 1995; 44: 658-664.
71. Somoza N, Vargas F, Roura-Mir C, et al. Pancreas in recent onset insulin-dependent diabetes mellitus. Changes in HLA, adhesion molecules and autoantigens, restricted T cell receptor V beta usage, and cytokine profile. J Immunol 1994; 153: 1360-1377.
72. Onodera T, Jenson AB, Yoon JW, Notkins AL. Virus-induced diabetes mellitus: reovirus infection of pancreatic beta cells in mice. Science 1978; 201: 529-531.
73. Roivainen M, Rasilainen S, Ylipaasto P, et al. Mechanisms of coxsackievirus-induced damage to human pancreatic beta-cells. J Clin Endocrinol Metab 2000; 85: 432-440.
74. Chehadeh W, Kerr-Conte J, Patton F, et al. Persistent infection of human pancreatic islets by coxsackievirus B is associated with alpha interferon synthesis in beta cells. J Virol 2000; 74: 10 153-10 164.
75. Shirali GS, Ni J, Chinnock RE, et al. Association of viral genome with graft loss in children after cardiac transplantation. N Engl J Med 2001; 344: 1498-1503.
76. Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD. How cells respond to interferons. Anna Rev Biochem 1998; 67: 227-264.
77. Flodstrom M, Maday A, Balakrishna D, Cleary MM, Yoshimura A, Sarvetnick N. Target cell defense prevents the development of diabetes after viral infection. Nat Immunol 2002; 3: 373-382.
78. Siegal FP, Kadowaki N, Shodell M, et al. The nature of the principal type 1 interferon-producing cells in human blood. Science 1999; 284: 1835-1837.
79. Cella M, Jarrossay D, Facchetti F, et al. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat Med 1999; 5: 919-923.
80. Steinman RM. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991; 9: 271-296.
81. Hyypia T, Hovi T, Knowles NJ, Stanway G. Classification of enteroviruses based on molecular and biological properties. J Gen Virol 1997; 78(Pt 1): 1-11.
82. Yin H, Berg AK, Tuvemo T, Frisk G. Enterovirus RNA is found in peripheral blood mononuclear cells in a majority of type 1 diabetic children at onset. Diabetes 2002; 51: 1964-1971.
83. Bailly JL, Chambon M, Henquell C, Icart J, Peigue-Lafeuille H. Genomic variations in echovirus 30 persistent isolates recovered from a chronically infected immunodeficient child and comparison with the reference strain. J Clin Microbiol 2000; 38: 552-557.
84. Roivainen M, Ylipaasto P, Savolainen C, Galama J, Hovi T, Otonkoski T. Functional impairment and killing of human beta cells by enteroviruses: the capacity is shared by a wide range of serotypes, but the extent is a characteristic of individual virus strains. Diabetologia 2002; 45: 693-702.
85. Seewaldt S, Thomas HE, Ejrnaes M, et al. Virus-induced autoimmune diabetes: most beta-cells die through inflammatory cytokines and not perform from autoreactive (antiviral) cytotoxic T-lymphocytes. Diabetes 2000; 49: 1801-1809.
86. Halim S, Ramsingh AI. A point mutation in VP1 of coxsackievirus B4 alters antigenicity. Virology 2000; 269: 86-94.
87. Ramsingh AI, Lee WT, Collins DN, Armstrong LE. Differential recruitment of B and T cells in coxsackievirus B4-induced pancreatitis is influenced by a capsid protein. J Virol 1997; 71: 8690-8697.
88. Conrad B, Weidmann E, Trucco G, et al. Evidence for superantigen involvement in insulin-dependent diabetes mellitus aetiology. Nature 1994; 371: 351-355.
89. Conrad B, Weissmahr RN, Boni J, Arcari R, Schupbach J, Mach B. A human endogenous retroviral superantigen as candidate autoimmune gene in type I diabetes. Cell 1997; 90: 303-313.
90. Murphy VJ, Harrison LC, Rudert WA, et al. Retroviral superantigens and type 1 diabetes mellitus. Cell 1998; 95; 9-11; discussion 16.
91. Kim A, Jun HS, Wong L, et al. Human endogenous retrovirus with a high genomic sequence homology with IDDMK(1,2)22 is not specific for Type I (insulin-dependent) diabetic patients but ubiquitous. Diabetologia 1999; 42: 413-418.
92. Jaeckel E, Heringlake S, Berger D, Brabant G, Hunsmann G, Manns MP. No evidence for association between IDDMK(1,2)22, a novel isolated retrovirus, and IDDM. Diabetes 1999; 48: 209-214.
93. Luppi P, Rudert WA, Zanone MM, et al. Idiopathic dilated cardiomyopathy: a superantigen-driven autoimmune disease. Circulation 1998; 98: 777-785.
94. Luppi P, Zanone MM, Hyoty H, et al. Restricted TCR V beta gene expression and enterovirus infection in type I diabetes: a pilot study. Diabetologia 2000; 43: 1484-1497.
95. Hanninen A, Jalkanen S, Salmi M, Toikkanen S, Nikolakaros G, Simell O. Macrophages, T cell receptor usage, and endothelial cell activation in the pancreas at the onset of insulin-dependent diabetes mellitus. J Clin Invest 1992; 90: 1901-1910.
96. Yamagata K, Nakajima H, Tomita K, et al. Dominant TCR alpha-chain clonotypes and interferon-gamma are expressed in the pancreas of patients with recent-onset insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 1996; 34: 37-46.
97. Stauffer Y, Marguerat S, Meylan F, et al. Interferon-alpha-induced endogenous superantigen - a model linking environment and autoimmunity. Immunity 2001; 15: 591-601.
98. Sutkowski N, Conrad B, Thorley-Lawson DA, Huber BT. Epstein-Barr virus transactivates the human endogenous retrovirus HERV-K18 that encodes a superantigen. Immunity 2001; 15: 579-589.
99. Sutkowski N, Palkama T, Ciurli C, Sekaly RP, Thorley-Lawson DA, Huber BT. An Epstein-Barr virus-associated superantigen. J Exp Med 1996; 184: 971-980.